News & Events

• April 7, 2021
  

  Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy Abstract WMS 2020

• April 7, 2021
  

  Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy poster WMS 2020

• April 7, 2021
  

  Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Abstract WMS 2019

• April 7, 2021
  

  Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Poster WMS 2019

• April 15, 2019
  

  Muscular Dystrophy Association 2019 Clinical and Scientific Conference

  Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Orlando, FL on April 14- April 16. She presented two posters: Development of a Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Consortium Value of Skeletal Muscle Damage Biomarkers as Pharmacodynamic Biomarkers for Neuromuscular......